Marshall Wace, LLP Viemed Healthcare, Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.04 - $8.45 $30,042 - $42,030	4,974 Added 28.26%	22,574 $177,000
Q3 2023 Nov 14, 2023	BUY	$6.73 - $9.85 $118,448 - $173,360	17,600 New	17,600 $118,000
Q1 2023 May 15, 2023	BUY	$7.55 - $10.2 $139,931 - $189,046	18,534 New	18,534 $179,000
Q3 2022 Nov 14, 2022	SELL	$5.43 - $7.96 $30,576 - $44,822	-5,631 Reduced 3.85%	140,687 $844,000
Q2 2022 Aug 15, 2022	BUY	$4.94 - $5.81 $201,680 - $237,199	40,826 Added 38.7%	146,318 $788,000
Q1 2022 May 16, 2022	BUY	$3.58 - $5.55 $377,661 - $585,480	105,492 New	105,492 $525,000
Q4 2020 Feb 16, 2021	SELL	$7.76 - $10.07 $330,312 - $428,639	-42,566 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.16 - $11.22 $347,338 - $477,590	42,566 New	42,566 $368,000

124

26.7M

2.4K

2.6K

Ticker VMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,222,000
Market Cap $328M
Description
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, per...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.